Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently used to alleviate pain of the patients who suffer from inflammatory conditions like rheumatoid arthritis, osteoarthritis, and other painful conditions like gout. This class of drugs works by blocking cyclooxgenases which in turn block the prostaglandin production in the body. Most often, NSAIDs and antihypertensive drugs are used at the same time, and their use increases with increasing age. Moreover, hypertension and arthritis are common in the elderly patients requiring pharmacological managements. An ample amount of studies put forth evidence that NSAIDs reduce the efficiency of antihypertensive drugs plus aggravate pre-existing hypertension or make the individuals prone to develop high blood pressure through renal dysfunction. This review will help doctors to consider the effects and risk factors of concomitant prescription of NSAIDs and hypertensive drugs.
Similar content being viewed by others
References
Sugano, K., Kinoshita, Y., Miwa, H., & Takeuchi, T. (2013). Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs. BMC Gastroenterology, 13, 54.
Timmers, L., Pasterkamp, G., & Kleijn, D. P. (2007). Microsomal prostaglandin E2 synthase: A safer target than cyclooxygenases? Molecular Interventions, 7(4), 195–199.
de Abajo, F. J., Gil, M. J., Bryant, V., Timoner, J., Oliva, B., & Garcia-Rodriguez, L. A. (2013). Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: A nested case–control study in a new general practice database. European Journal of Clinical Pharmacology, 69(3), 691–701.
Cekin, A. H., Taskoparan, M., Duman, A., Sezer, C., Cekin, Y., Yolcular, B. O., et al. (2012). The role of helicobacter pylori and NSAIDs in the pathogenesis of uncomplicated duodenal ulcer. Gastroenterology Research and Practice, 2012, 189373.
Nawaz, F. A., Larsen, C. P., & Troxell, M. L. (2013). Membranous nephropathy and nonsteroidal anti-inflammatory agents. American Journal of Kidney Disease, 62(5), 1012–1017.
Dhanvijay, P., Misra, A. K., & Varma, S. K. (2013). Diclofenac induced acute renal failure in a decompensated elderly patient. Journal of Pharmacology Pharmacotherapeutics, 4(2), 155–157.
Aljadhey, H., Tu, W., Hansen, R. A., Blalock, S. J., Brater, D. C., & Murray, M. D. (2012). Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovascular Disorders, 12, 93.
Bavry, A. A., Khaliq, A., Gong, Y., Handberg, E. M., Cooper-Dehoff, R. M., & Repine, C. J. (2011). Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. American Journal of Medicine, 124(7), 614–620.
Zhang, Y. P., Zuo, X. C., Huang, Z. J., Cai, J. J., Wen, J., & Duan, D. D. (2013). CYP3A5 polymorphism, amlodipine and hypertension. Journal of Human Hypertension,. doi:10.1038/jhh.2013.67.
Boyden, L. M., Choi, M., Choate, K. A., Nelson-Williams, C. J., Farhi, A., Toka, H. R., et al. (2012). Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature, 482(7383), 98–102.
Cheung, B. M. Y., & Li, C. (2012). Diabetes and hypertension: Is there a common metabolic pathway? Current Atherosclerosis Reports, 14(2), 160–166.
Fournier, J. P., Sommet, A., Bourrel, R., Oustric, S., Pathak, A., Lapeyre-Mestre, M., et al. (2012). Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: A population-based cohort study. European Journal of Clinical Pharmacology, 68, 1533–1540.
Lapi, F., Azoulay, L., Yin, H., Nessim, S. J., & Suissa, S. (2013). Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: Nested case–control study. BMJ, 8346, e8525.
Moon, K. W., Kim, J., Kim, J. H., Song, R., Lee, E. Y., Song, Y. W., et al. (2011). Risk factors for acute kidney injury by non-steroidal anti-inflammatory drugs in patients with hyperuricaemia. Rheumatology, 50(12), 2278–2282.
Wei, L., Macdonald, T. M., Jennings, C., Sheng, X., Flynn, R. W., & Murphy, M. J. (2013). Estimated GFR reporting is associated with decreased nonsteroidal anti-inflammatory drug prescribing and increased renal function. Kidney International, 84(1), 174–178.
John, C. M., Shukla, R., & Jones, C. A. (2007). Using NSAID in volume depleted children can precipitate acute renal failure. Archives of Disease in Childhood, 92(6), 524–526.
Kateros, K., Doulgerakis, C., Galanakos, S. P., Sakellariou, V. I., Papadakis, S. A., & Macheras, G. A. (2012). Analysis of kidney dysfunction in orthopaedic patients. BMC Nephrology, 13, 101.
Yu, Y., Ibrahim, S., Song, W. L., Smyth, E. M., Funk, C. D., & FitzGerald, G. A. (2010). Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: Targeted exchange of cyclooxygenase isoforms in mice. Circulation Research, 106(2), 337–345.
Houston, M. C. (1991). Nonsteroidal anti-inflammatory drugs and antihypertensives. American Journal of Medicine, 90(5A), 42S–47S.
Polonia, J. (1997). Interaction of antihypertensive drugs with anti-inflammatory drugs. Cardiology, 88(Suppl 3), 47–51.
Fournier, J. P., Sommet, A., Bourrel, R., Oustric, S., Pathak, A., Lapeyre-Mestre, M., et al. (2012). Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: A population-based cohort study. European Journal of Clinical Pharmacology, 68, 1533–1540.
Hamzat, T. K., & Ajala, A. O. (2010). Interaction between anti-hypertensive and non-steroidal antiinflammatory drugs: Implications in management of osteoarthritis and opinion on a compromise therapy. Internet Journal of Medical Update, 5(1), 42–47.
Bavry, A. A., Khaliq, A., Gong, Y., Handberg, E. M., Cooper-DeHoff, R. M., & Pepine, C. J. (2011). Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. American Journal of Medicine, 124(7), 614–620.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zheng, L., Du, X. Non-steroidal Anti-inflammatory Drugs and Hypertension. Cell Biochem Biophys 69, 209–211 (2014). https://doi.org/10.1007/s12013-013-9791-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-013-9791-5